The development of progressive glomerulosclerosis in the renal ablation model has been ascribed to a number of humoral and hemodynamic events, including the peptide growth factor, transforming growth factor-j31 (TGF-fi1).
less and inevitable decline in renal function ( 1) . The sclerotic lesion results from the progressive accumulation of several extracellular matrix (ECM)' proteins (2) , and much effort has been directed towards determining the molecular mechanisms underlying this event. Subtotal renal ablation (5/6 nephrectomy) in adult rats has served as a useful and extensively studied animal model of this process. Subtotal ablation elicits a complex glomerular response, initially consisting of a rapid hypertrophic phase, followed by a variable period of relative quiescence, and finally by the development of segmental glomerular sclerosis (3, 4) . This evolving pattern of injury has been attributed to a number of diverse factors accruing as the result of loss of renal mass, including metabolic, hematologic, and hemodynamic alterations (4) (5) (6) . The renin-angiotensin system contributes substantially to the development of glomerular sclerosis after 5/6 nephrectomy. Angiotensin II (All) receptor blockade (7, 8) or the inhibition of All synthesis by converting enzyme inhibitors (9, 10) markedly retards disease progression after renal ablation. Preventing the production of All can also limit the progression of pre-existing glomerular injury ( 11) . Since All has multiple cellular effects in addition to its role in hemodynamic regulation (12, 13) , the precise role of this hormone in the development of glomerular sclerosis remains uncertain. Additionally, the initial stimulus and the specific cellular origins of All within the glomerulus remain to be defined.
Recent studies in other vascular tissues have suggested that some of the pathophysiologic actions of All result from its stimulation of TGF-/3 expression (14, 15) . The TGF-,6s are a multifunctional family of peptides that modulate a wide range of processes, including wound healing, cell growth and differentiation, and is involved in embryogenesis (16) . These peptides also have multiple effects on glomerular cell functions, including modulation of the synthesis of ECM proteins and of the secretion of proteinases and proteinase inhibitors (17) (18) (19) (20) (21) (22) (23) .
TGF-f31, the most extensively studied form, is particularly important as it mediates the actions of other cytokines and, significantly, can stimulate its own expression (24) . The TGF-ps, and TGF-,61 in particular, have also been implicated in the progression of several models of glomerular disease, including immune complex-mediated glomerulonephritis (25) (26) (27) (28) (29) , antiglomerular basement membrane disease (30) , and diabetic glomerulosclerosis (31) . In addition, unilateral nephrectomy in rats-has been shown to induce changes in TGF-131 gene expression in remnant glomeruli (32) .
The endothelial cell plays a central role in many of the pathophysiologic processes affecting vascular tissues. Vascular endothelial cells secrete multiple vasoactive substances critical in the regulation of vascular tone, as well as a wide array of cytokines and growth factors, such as TGF-/3 (33) and All 1. Abbreviations used in this paper: All, angiotensin II; ECM, extracellular matrix; GBM, glomerular basement membrane; ISRT, in situ reverse transcription.
Endothelial Injury and Glomerular Sclerosis (34) . Furthermore, the endothelial cell appears to be a critical mediator in the progression of vascular disease (33, 35) , where endothelial cell injury results in local increases in angiotensinogen and, presumably, All expression (33, 36) . After renal ablation Kriz and colleagues (37) have noted that endothelial cells in areas destined to develop sclerosis exhibit ultrastructural changes of cellular injury. This suggests that the development of glomerular sclerosis is in some respects similar to the injury pattern in other vascular systems.
All plays a role in vascular injury and has been clearly implicated as a central mediator in the development of sclerosis in several disease models. We therefore hypothesized that increased local generation of All, resulting from enhanced local angiotensinogen synthesis, occurs in areas of glomerular microvascular injury. Local All generation, in turn, stimulates increased TGF-,31 synthesis by intrinsic glomerular cells, leading to ECM accumulation and, ultimately, segmental glomerular sclerosis. Using a recently developed in situ reverse transcription technique (ISRT, reference 38), we evaluated the specific cell types and the temporal patterns of expression for several relevant mRNAs within the glomerulus after subtotal renal ablation. The mRNAs studied included angiotensinogen, TGF-/31, and three glomerular ECM protein components: fibronectin, a-I (IV) collagen, and laminin B 1. The kidneys were perfusion fixed with 4% paraformaldehyde in PBS, pH 7.4, and cortical tissue blocks were harvested and snap frozen in isopentane cooled with liquid nitrogen. ISRT and histologic studies were performed as described below.
In situ reverse transcription. The ISRT procedure was performed as described in detail (38) . In brief, 6 /m cryostat sections of perfusionfixed kidney tissue blocks were mounted on slides previously subbed with 2% 3-aminopropyltriethoxysilane in acetone, fixed in 4% paraformaldehyde for [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] min, and washed with PBS and water. Sections were delipidated with graded ethanol washes, rehydrated, then permeabilized in 0.1% Triton X-100 (90-105 s). The detergent was neutralized in 100 mM Tris/HCl, pH 7.4, followed by an avidin-biotin blocking step, pre-incubation in 100 mM Tris/HCl, pH 7.4, and prehybridization for at least 30 min at room temperature in: 20 mM Tris/HCl, pH 7.4, 2 mM EDTA, 0.04% BSA, 150 mM NaCl, 200 Ag/ml yeast tRNA, and 200 Ag/ml salmon sperm DNA. Hybridization was then carried out overnight at room temperature in a humidified chamber with specific primers (24-27 mers, 100 ng/ml of prehybridization solution). Tissues were washed in 1 X SSC, pH 7.0, followed by a 5-min pre-incubation in 50 mM Tris/HCl, pH 8.0, 120 mM KCl, 10 mM MgCl2. Primer extension was performed at 37°C for 90 min using a solution consisting of 50 mM Tris/HCl, pH 8.0, 120 mM KCl, 10 mM MgCl2, 7.5 mM DTT, 100 Ag/ml actinomycin-D, 0.01% Triton X-100, 120 U/ml placental ribonuclease inhibitor, 200 U/ml AMV Reverse Transcriptase, 50 ,uM biotin-7-dATP, and 600 ,uM each of dCTP, dGTP, and dTTP. After reverse transcription, the sections were washed at room temperature in 1 x SSC, then 0.1 X SSC, and finally PBS. After blocking with 3% normal rabbit serum, sections were incubated with primary antibody (using either 2 Ag/ml goat anti-biotin IgG in 0.1% BSA in PBS, incubated overnight at 4°C, or 2 Ag/ml monoclonal mouse anti-biotin in 0.1% BSA in PBS, incubated for 30 min at 37°C), washed in PBS, and then incubated at 4°C for 4 h with secondary antibody (5 jig/ml biotinylated rabbit anti-goat IgG or 1.3 Ag/ml biotinylated rabbit antimouse in 0.1% BSA or 0.1% BSA/2% rat whole serum in PBS). After washing in PBS, an ABC-peroxidase or ABC-alkaline phosphatase detection system was applied (ABC-alkaline phosphatase application was preceded by a 3-5-min treatment in Bouin's fixative, then washed in PBS), using the corresponding substrate reagent (DAB/NiCl2 medium for peroxidase detection, or the alkaline phosphatase substrate reagent). The reaction was terminated at 10-15 min. Slides were then counterstained with methyl green, dehydrated and mounted. Negative controls included performance of ISRT without a specific oligonucleotide primer or with sense primers. All tissue sections were viewed with a Zeiss Axiophot microscope using Nomarski optics. Serial sections containing at least 20 glomeruli of multiple tissue blocks (usually 3-5) from each experimental animal were examined. To determine semiquantitatively the number of a-I (IV) collagen mRNA expressing cells, the number of histochemically stained cells were counted in 25-30 glomerular tufts (80-100 A a diameter) from each studied kidney (n = 5-8, as previously noted). Results are expressed as the mean±1 SD of positive cells per glomerular cross-section.
Oligonucleotide primers. Oligonucleotide primers were synthesized on an Applied Biosystems 391 DNA Synthesizer (Applied Biosystems, Foster City, CA). The primer sequences are as follows: a-I (IV) collagen (murine sequence, nucleotides 582-606), 5'-CAACATCTCGCT-TCTCTCTATGGTG-3'; angiotensinogen (rat sequence, nucleotides 1452-1477), 5 '-GTTATCCACTCTGCCCAGAAAGTGC-3'; fibronectin (rat sequence, nucleotides 265-289), 5'-CTGTGGACTGGAC- TCCAATCAGGGG-3'; laminin-B1 (murine sequence, nucleotides 509-532), 5 '-CCACACCATI~CCGATTGCCACC-3'; TGF /3-1 (rat sequence, nucleotides 1422-1446), 5'-TGGTTGTAGAGGG-CAAGGACC-lGC-3'. Control primers reflect the matching sense sequences. The sequences of all candidate primers, including control sense primers, were extensively searched against the EMBL and National Institute of Health Genbank databases, and any primers exhibiting high degrees of homology, particularly at the 3' end, to sequences other than the mRNA of interest were discarded. Additionally, the highly conserved structural motifs found in the TGF-,f and ECM protein families were avoided, thereby insuring the specificity of the primers used.
Histologic studies. the late sclerotic stage, extensive segmental sclerosis in various degrees of evolution was observed in the majority of glomeruli (Fig. 1 D) . Patterns of matrix protein gene expression. In a previous ISRT study (38) , which localized the mRNAs of nine major glomerular matrix proteins in the mature rat, we demonstrated the asymmetric nature of glomerular basement membrane (GBM) protein synthesis and the contribution of all three glomerular cell types to this process. Notable in this study was the relatively limited cellular distribution of fibronectin (mesangial cells), laminin Bi (mesangial cells), and a-l (IV) collagen (endothelial cells) mRNAs. The distribution of a-I (IV) collagen mRNA was highly restricted, appearing in only a subset of endothelial cells lining capillary lumina of small diameter. In applying ISRT to the renal ablation model, we reasoned that changing cellular patterns of matrix protein gene expression would be more readily detected by studying mRNAs normally limited in their range of expression. Thus, primers to detect a-1 (IV) collagen, laminin B 1, and fibronectin mRNAs were chosen for the studies described herein.
The mRNAs for a-i (IV) collagen, the major structural GBM component, was found only within a limited subset of endothelial cells in control animals (Fig. 2 A) with an average of 12±4 positively stained cells per glomerular cross-section.
This pattern changed dramatically in both number and distribution following renal ablation. At 14 d after ablation a-I (IV) collagen mRNA was detected in all three glomerular cells types (i.e., mesangial, epithelial, and endothelial) with 52±17 cells per glomerular cross-section expressing this RNA transcript (Fig. 2 B) . By 24 d after ablation, a-I(IV) collagen mRNA was detected in relatively fewer cells (24±8 cells per glomerular cross-section), demonstrating an association between the stabilization of glomerular hypertrophy and the reversal of the previously augmented expression of this mRNA (Fig. 2 C) .
The overall distribution of cells positive for a-I (IV) collagen mRNA diminished further as segmental sclerosis appeared, and by 69 d after ablation a-i (IV) collagen expression resembled the patterns of limited, heterogeneous endothelial cell expression (19±5 cells per glomerular cross-section) seen in control animals (Fig. 2 D) . Notably, areas of evolving segmental sclerosis did not exhibit any significant a-1 (IV) collagen mRNA expression.
Laminin B 1 mRNA in control animals was restricted to the mesangium (Fig. 3 A) , consistent with our previous findings for this matrix protein component (38) . As with a-1 (IV) collagen mRNA, laminin B 1 mRNA expression and distribution changed significantly during the hypertrophic period following ablation. At 6 days following ablation visceral glomerular epithelial cells, which normally do not express laminin B1, were observed to express this mRNA (Fig. 3 B) . By day 24 laminin B1 mRNA was no longer present in visceral epithelial cells, while, for the first time, endothelial cell expression was evident (Fig. 3 C) . In contrast to a-I (IV) collagen mRNA, laminin B 1 mRNA was prominently expressed during the late sclerotic stage. At 74 d following renal ablation the mRNA for this protein localized within both mesangial and endothelial cells and was especially prominent in areas of segmental sclerosis (Fig. 3 D) .
The cellular distribution of fibronectin mRNA during the early stage of glomerular hypertrophy contrasted markedly with the augmented cellular expression patterns observed for a-1 (IV) collagen and laminin BI mRNAs. Fibronectin mRNA distribution, normally limited to mesangial cells (Fig. 4 A) , remained relatively unchanged-during the development of glomerular hypertrophy (Fig. 4 B) . By the pre-sclerotic stage occasional endothelial cells stained positive for fibronectin mRNA (Fig. 4 C) . This became much more pronounced as sclerosis developed. By 74 d after following ablation fibronectin mRNA staining was observed within both mesangial and endothelial cells with particularly heavy staining patterns noted in foci of sclerotic injury (Fig. 4 D) . of TGF-/1 and angiotensinogen mRNA expression were noted following subtotal renal ablation. In controls angiotensinogen mRNA staining was limited to a scattered mesangial cell distribution (Fig. 5 A) . In contrast, TGF-,11 mRNA was found in a significant fraction of mesangial cells within each glomerulus (Fig. 6 A) , a pattern that we have previously reported (23) . There were no significant changes in the distribution of angiotensinogen and TGF-B3I mRNA staining during the early stage following renal ablation (Figs. 5 B and 6 B, respectively) , while rather dramatic alterations were observed at day 24. At this presclerotic stage mRNAs for angiotensinogen were found within the endothelial cells lining dilated capillary loops at the vascular pole (Fig. 5 C) . The expression of angiotensinogen mRNA within the endothelium of these enlarged capillary loops was occasionally accompanied by prominent angiotensinogen mRNA staining within neighboring mesangial cells. TGF-,31 mRNA expression and distribution were also dramatically altered at 24 d after ablation. As with angiotensinogen mRNA, TGF-f31 mRNA staining was detected within the endothelium of widened capillary loops, in addition to surrounding mesangial cells (Fig. 6 C) . Additional ISRT analyses on consecutive tissue sections, alternating between angiotensinogen and TGF-f31 mRNA detection, revealed these two mRNAs co-localizing to the same endothelial and mesangial cells during this pre-sclerotic stage (Fig. 7, A and B) . Even more extensive staining for these two mRNAs was noted as the disease process progressed. In the glomeruli from rats sacrificed 74 d after renal ablation, both angiotensinogen (Fig. 5 D) and TGF-31 (Fig. 6 D) mRNAs were evident within numerous mesangial and endothelial cells located within and around evolving sclerotic foci.
The association between angiotensinogen and TGF-,B1 mRNA expression was further investigated by examining the effects of losartan administration, which was started at the time of renal ablation. Losartan is a noncompetitive inhibitor of AT I receptors (41) , and the treatment regimen used in this study has previously been shown to inhibit the development of segmental Endothelial Injury and Glomerular Sclerosis sclerosis 10 wk after 5/6 nephrectomy (7). Losartan treated animals were studied with ISRT at 24 d after ablation, coinciding with the earliest observed changes in angiotensinogen and TGF-f31 mRNA expression in untreated animals. In glomeruli from treated animals angiotensinogen (Fig. 7 C) and TGF-P1 (Fig. 7 D) mRNAs were primarily limited to a sparse, scattered mesangial cell distribution. Rare endothelial cell staining of angiotensinogen mRNA was observed, and TGF-,e1 mRNA was virtually absent from the endothelium. These patterns contrasted markedly with those observed in the untreated cohorts (Fig. 7,  A and B) . In addition, losartan treatment blocked the abnormal expression of laminin B 1 and fibronectin mRNAs by the endothelium (Fig. 8) .
Discussion
The morphologic transformations that characterize the remnant ations in one or more of the intrinsic glomerular cells. Improved mRNA localization methodologies provide new insights into evaluating these phenotypic changes. Since complete dissociation of mRNA expression from synthesis of its protein translation product occurs in only rare instances, information obtained from such techniques can also provide persuasive evidence for the cellular origins of proteins within the glomerulus (38) .
The early post-ablation period is an adaptive compensatory response that is associated with a rapid increase in glomerular size. Our findings of augmented a-i (IV) collagen and laminin B1 gene expression by multiple cell types suggest that the demands of new GBM synthesis during this hypertrophic process lead to the recruitment of additional cell types to synthesize these critical component proteins. As a principal structural component of the normal GBM, the increased synthesis of a-I (IV) collagen during this early period is not an unexpected finding. The enhanced epithelial cell synthesis of laminin BI is unexkidney model result from an evolving series of phenotypic alterpected, since in the mature glomerulus laminin B1 is present only in the mesangial matrix and not within the GBM (42) . Data obtained from Northern blot (43) , in situ hybridization (44) , and immunohistochemical studies (45) all suggest that the laminin B 1 protein is a major basement membrane component in the developing glomeruli of fetal and newborn rats.
Immunolocalization studies have also shown that a-1 (IV) collagen is synthesized by multiple glomerular cell types during development (43, 46, 47) . Therefore, in at least these two respects, the early glomerular response to subtotal renal ablation represents a recapitulation of fetal patterns of GBM synthesis.
In the intermediate pre-sclerotic phase, expression of a-1 (IV) collagen mRNA approached its baseline pattern, coinciding with the stabilization of hypertrophy. During this period, however, the first sign of pathologically significant shifts in cellular matrix synthesis patterns was detected, namely, the appearance of fibronectin and laminin B lmRNAs within endothelial cells. The endothelial cell expression of fibronectin becomes more extensive as segmental sclerosis develops, as evidenced by the fibronectin mRNA staining within nearly all endothelial and mesangial cells within sclerotic foci. These mRNA localization results corroborate immunohistochemical studies demonstrating heavy fibronectin staining within the glomerular sclerotic lesions after renal ablation (48) . In addition to endothelial and mesangial expression of fibronectin within sclerotic foci, laminin B 1 mRNA expression followed a similar pattern, suggesting that this protein is a substantial component of sclerotic lesions as well. In contrast, mRNAs for a-I (IV) collagen were conspicuously absent in these advanced lesions.
These mRNA localization patterns demonstrate that the major phases of the glomerular morphologic response to subtotal renal ablation are associated with distinct cellular patterns of matrix protein gene expression. The and progressive renal failure are the ultimate result of subtotal renal ablation, this late response, characterized by discoordinate matrix protein gene expression, can be considered maladaptive.
Angiotensinogen and TGF-/31 mRNA expression only became more prevalent when the glomerular growth following renal ablation had stabilized. Particularly significant was the appearance of both mRNAs within the endothelial cells lining dilated capillary loops, as well as their co-localization within the same cells. Focal augmentation in mesangial cell angiotensinogen mRNA expression was also observed, but only in the context of adjacent endothelial cell expression.
Recent studies, using another model of glomerular sclerosis (uninephrectomy in young rats, references 37 and 49) , have demonstrated that the capillary loop dilation following renal ablation is associated with a number of ultrastructural abnormalities in endothelial cells, as well as in adjacent mesangial cells and podocytes. These capillary loop alterations occurred primarily near the vascular pole and most frequently involved the first branches of afferent arterioles. This is consistent with our current light microscopic findings. It was furthermore noted that glomerular tuft adhesions and sclerosis eventually developed at these same locations, demonstrating an association between the dilation and injury of the endothelium and the subsequent development of segmental glomerular sclerosis. These studies, in conjunction with our data for angiotensinogen, TGF-,/1, fibronectin, and laminin B1 mRNA localization, suggest that endothelial cell injury, or activation, mediates the alterations in glomerular cell biology that ultimately result in segmental sclerosis.
Capillary dilation following renal ablation may result from a number of hemodynamic alterations. One consistent finding following subtotal renal ablation is glomerular capillary hypertension. Results from numerous studies have established that this is a critical pathophysiologic component in the development of sclerosis (4) (5) (6) (7) (8) (9) (10) (11) . Increased capillary pressure is a possible stimulus for the phenotypic changes observed in this study. An effect of increased capillary pressure is an increase in capillary wall tension, particularly in capillaries with increased diameters.
The appearance of angiotensinogen and TGF-P1 mRNA expression, primarily along widened capillary loops, coincides with areas of increased wall tension, suggesting that this may also be a stimulus for angiotensinogen and TGF-,81 expression.
Change in fluid shear stress is a third possible outcome of structural alterations in capillary loops, and recent studies have demonstrated activation of endothelial cell gene transcription in response to such changes (50, 51) . Fluid shear stress can result in increased endothelial expression of platelet-derived growth factor (PDGF), a response that is critically dependent upon a hexanucleotide motif contained within the promoter region of the PDGF gene (51 ) . Particularly relevant to this study is the presence of this motif within the promoter region of the TGF-f31 gene (51) and in regions of the angiotensinogen gene that are common binding locations for transcription factors. This current study suggests that hemodynamic factors, widely implicated as a cause of glomerular sclerosis, provide the initial stimulus for endothelial angiotensinogen and TGF-f31 mRNA expression. The relative importance of these factors in the pathophysiology of this process, however, is not directly addressed by the findings in this study.
In addition to stimulating TGF-3il expression, All has also been shown to mediate the expression of a number of other cytokines and growth factors, including PDGF (14, 52) and basic fibroblast growth factor (52) . In particular, transient increases in PDGF expression have been observed during the early stages after subtotal renal ablation (53), a response that can be diminished by inhibiting angiotensin converting enzyme activity (54) . This suggests that PDGF may also have a prominent role in the pathophysiology of this process. Therefore, the endothelial cell expression of angiotensinogen mRNA that we observed following renal ablation is likely to induce the expression of other cytokines, in addition to TGF-f31, that may be important in the development of glomerular sclerosis. In this study we have focused our attention on TGF-,31 expression, since this protein has been clearly linked to the development and progression of sclerosis in numerous glomerular disease models (25) (26) (27) (28) (29) (30) (31) .
Although ISRT does not quantify levels of mRNA expression, other recent investigations support our findings which suggest that locally generated AII induces glomerular TGF-B31, and hence, ECM protein mRNA expression. Border and colleagues (55) have observed increased TGF-,61 and fibronectin mRNA levels (6.1-and 4.0-fold, respectively, at 8 h) by cultured mesangial cells in response to AII treatment. This response could be prevented by All receptor antagonists. In addition, All enhanced the conversion of latent TGF-/.1 into its biologically active form. In the renal ablation model Juanid et al. (56) , used Northern blot analysis of total glomerular RNA to measure the temporal changes in TGF-,61 mRNA levels and the effects of losartan on these changes. In this study AII receptor blockade reduced TGF-,31 mRNA levels by > 50% compared with controls. Furthermore, Schunkert et al. (57) , have demonstrated increased kidney angiotensinogen mRNA expression in response to intravenous All infusions, consistent with our observation of diminished angiotensinogen mRNA expression with All receptor blockade. In addition to corroborating these prior measurements, our results provide insightful cellular localization information unobtainable by Northern blot analyses.
Dzau and colleagues have provided evidence that paracrine/ autocrine interactions between endothelial and smooth muscle cells are important in normal vascular physiology. They have also demonstrated that such interactions are also critical in vascular disease processes (33, 36, 58) . This endothelial-smooth muscle interdependency may be particularly relevant to glomerular disease, as the glomerular mesangial cell and the vascular smooth muscle cell share many common features (6, 53, 59) . Thus, our findings also indicate that mesangial cell-endothelial cell communication is critical in the development of segmental glomerular sclerosis.
As the interface between the blood and remaining glomerular tissue, the glomerular endothelium is ideally situated to serve as a principal mediator of renal disease processes. As the understanding of endothelial cell biology expands, traditional views of the glomerular endothelium as a biologically inert cell layer becomes increasingly untenable. Difficulties in maintaining pure glomerular endothelial cell cultures have, unfortunately, limited investigations in this area, and extensive evidence for endothelial involvement in glomerular disease is lacking. The results of this study do, however, establish that induction of TGF-,ll, fibronectin, and laminin BI mRNA expression by the glomerular endothelium may be important in the progression of glomerular disease. Our findings have also provided insights regarding the role of All in glomerular sclerosis, demonstrating the cellular origins of this hormone in relation to the altered glomerular capillary architecture found subsequent to renal ablation. The initial pathophysiologic stimulus of hemodynamic injury to the endothelium results in local All generation, presumably resulting from endothelial expression of angiotensinogen. This locally generated All acts on adjacent mesangial and additional endothelial cells, inducing the expression of TGF-031 and, possibly, other cytokines and growth factors. The selfamplifying properties of these agents result in a cascade of growth factor synthesis which, ultimately, lead to uncontrolled matrix protein accumulation characteristic of the segmental glomerular sclerotic lesion.
